Elsevier,
Neuroscience, Volume 546, 14 May 2024
This study investigated VGLUT1 and VGLUT2 expression in the medial temporal lobe and superior temporal gyrus in Alzheimer's disease (AD). The findings reveal region-specific vulnerabilities, with significantly lower VGLUT1 in the dentate gyrus and VGLUT2 in the subiculum and superior temporal gyrus, suggesting potential therapeutic targets that require further exploration.
Elsevier,
Pharmacological Research, Volume 203, May 2024
This article explores the link between alcohol consumption and Alzheimer’s disease (AD), focusing on how serotonergic dysfunction may mediate this relationship. It highlights the roles of neuroinflammation and proteostasis in this process
Elsevier,
Journal of Ginseng Research, Volume 48, May 2024
This review describes recent clinical contributors to ginseng components in clinical tests and introduces emerging evidence that ginseng components could be novel candidates for cognitive improvement in older individuals, as ginseng components improve SMI cognition and exhibits add-on effects when co-administered with early AD dementia drugs. The mechanism behind the beneficial effects of ginseng components and how it improves cognition are presented.
Elsevier,
Behavioural Brain Research, Volume 465, 8 May 2024
This article discusses age-related changes in species-typical behaviors, such as exploration and grooming, in female 5xFAD mouse model of Alzheimer's disease, suggesting that these behaviors may serve as valuable indicators for modeling the decline in activities of daily living observed in AD patients and assessing the efficacy of potential therapeutics.
Elsevier,
American Journal of Transplantation, Volume 24, May 2024
Nearly 2.4% of global deaths in 2019 were attributed to cirrhosis, which has increased since 2017. Liver transplantation (LT) is accepted as a lifesaving therapy for patients with complications of cirrhosis or hepatocellular cancer, but there are several barriers toward equitable access. This article outlines ways to reduce the disparities
Elsevier,
The Lancet Global Health, Volume 12, May 2024
This Article supports SDG 3 by demonstrating the effectiveness of assisted partner services in Kenya to test the partners of people who inject drugs for HIV and hepatitis C, and support linkage to and engagement in care among those who are positive for either infection.
Elsevier,
The Lancet Regional Health - Western Pacific, Volume 46, May 2024
This Article supports SDG3 by investigating the barriers to receiving childhood hepatitis B vaccines in Laos. The findings suggest that socioeconomic factors play a substantial role in the variation in vaccine coverage, particularly household income and education.